Ian T. Bothwell - 01 Jun 2021 Form 4 Insider Report for Organicell Regenerative Medicine, Inc. (OCEL)

Role
Chief Financial Officer, Director, 10%+ Owner
Signature
/s/ Ian Bothwell
Issuer symbol
OCEL
Transactions as of
01 Jun 2021
Transactions value $
-$24,500
Form type
4
Date filed
03 Jun 2021, 21:45
Previous filing
28 May 2021
Next filing
08 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCEL Common Stock Sale -$9.6K -50K -0.03% $0.19 149M 01 Jun 2021 Direct
transaction OCEL Common Stock Sale -$8.5K -50K -0.03% $0.17 149M 02 Jun 2021 Direct
transaction OCEL Common Stock Sale -$6.4K -40K -0.03% $0.16 149M 02 Jun 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.